BUNMI OGUNGBEJE: Open Payments
NPI 1386065027 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,129 in 120 payments from 13 companies in 2025. Trend: 2023 $1,087 · 2024 $1,177 · 2025 $2,129
Food & beverage: $1,921Education: $207
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 34 | $682 |
| Neurocrine BioSciences, Inc. | 13 | $288 |
| ABBVIE INC. | 29 | $276 |
| Alkermes, Inc. | 11 | $235 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $161 |
| Otsuka America Pharmaceutical, Inc. | 11 | $139 |
| Vanda Pharmaceuticals Inc. | 4 | $99 |
| Lundbeck LLC | 4 | $79 |
| Janssen Pharmaceuticals, Inc | 3 | $71 |
| E.R. Squibb & Sons, L.L.C. | 1 | $35 |
Products named: UZEDY, INGREZZA, VRAYLAR, ARISTADA, CAPLYTA, AUSTEDO XR, ABILIFY MAINTENA, FANAPT.
Industry payments across GA — which companies pay providers there.
